Does LETROZOLE Cause Malignant neoplasm progression? 3,445 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 3,445 reports of Malignant neoplasm progression have been filed in association with LETROZOLE (Letrozole). This represents 11.1% of all adverse event reports for LETROZOLE.
3,445
Reports of Malignant neoplasm progression with LETROZOLE
11.1%
of all LETROZOLE reports
506
Deaths
517
Hospitalizations
How Dangerous Is Malignant neoplasm progression From LETROZOLE?
Of the 3,445 reports, 506 (14.7%) resulted in death, 517 (15.0%) required hospitalization, and 108 (3.1%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LETROZOLE. However, 3,445 reports have been filed with the FAERS database.
What Other Side Effects Does LETROZOLE Cause?
Neutropenia (3,683)
Fatigue (3,568)
Nausea (2,894)
Arthralgia (2,318)
Diarrhoea (2,282)
Metastases to bone (1,735)
Dyspnoea (1,621)
Asthenia (1,589)
Vomiting (1,560)
Breast cancer metastatic (1,540)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
OSIMERTINIB (2,920)
Which LETROZOLE Alternatives Have Lower Malignant neoplasm progression Risk?
LETROZOLE vs LETROZOLE\RIBOCICLIB
LETROZOLE vs LEUCOVORIN
LETROZOLE vs LEUCOVORIN\LEUCOVORIN
LETROZOLE vs LEUPROLIDE
LETROZOLE vs LEVALBUTEROL